Skip to main content
TipRanks
Go Ultimate75% OFF

Yarrow Bioscience (YARW) Ratios

1,907 Followers

Yarrow Bioscience Ratios

YARW's free cash flow for Q3 2026 was $-89.96M. For the 2026 fiscal year, YARW's free cash flow was increased by $0.00 and operating cash flow was $-89.96M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio12.534.3512.734.103.43
Quick Ratio12.534.3512.734.103.04
Cash Ratio10.031.344.063.312.29
Solvency Ratio-11.05-2.69-3.18-2.42-3.98
Operating Cash Flow Ratio-13.83-2.29-3.36-3.12-3.06
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset Value$ 27.61M$ 49.62M$ 87.01M$ 28.72M$ 44.78M
Leverage Ratios
Debt-to-Assets Ratio0.000.000.000.000.01
Debt-to-Equity Ratio0.000.000.000.000.01
Debt-to-Capital Ratio0.000.000.000.000.01
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.091.281.101.311.38
Debt Service Coverage Ratio0.000.000.000.00-7.00
Interest Coverage Ratio0.000.000.000.00-6.94
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.000.000.020.002.08
Net Debt to EBITDA0.900.501.040.901.08
Profitability Margins
Gross Profit Margin95.96%100.00%100.00%100.00%100.00%
EBIT Margin-4689.82%-7944.71%-6900.47%-7189.73%-4179.48%
EBITDA Margin-4685.79%-7943.91%-6900.47%-7174.63%-4167.78%
Operating Profit Margin-5219.12%-8709.98%-6900.47%-7189.73%-4179.48%
Pretax Profit Margin-4689.82%-7944.71%-6573.58%-7113.63%-4700.32%
Net Profit Margin-4646.14%-7950.90%-6710.38%-4865.83%-7876.37%
Continuous Operations Profit Margin-4690.53%-7945.51%-6573.58%-7116.35%-4748.44%
Net Income Per EBT99.07%100.08%102.08%68.40%167.57%
EBT Per EBIT89.86%91.21%95.26%98.94%112.46%
Return on Assets (ROA)-87.81%-59.54%-29.13%-56.95%-109.37%
Return on Equity (ROE)-95.38%-76.48%-32.06%-74.39%-150.77%
Return on Capital Employed (ROCE)-107.15%-83.78%-32.46%-109.17%-80.00%
Return on Invested Capital (ROIC)-107.15%-83.62%-32.41%-109.17%-79.43%
Return on Tangible Assets-87.81%-59.54%-29.13%-56.95%-109.37%
Earnings Yield-106.73%-27.92%-118.87%-269.82%-139.70%
Efficiency Ratios
Receivables Turnover0.000.000.000.100.12
Payables Turnover0.020.000.000.000.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover6.332.432.050.002.63
Asset Turnover0.020.010.000.010.01
Working Capital Turnover Ratio0.010.010.010.010.02
Cash Conversion Cycle-16520.220.000.003826.002972.93
Days of Sales Outstanding0.000.000.003826.002972.93
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding16520.220.000.000.000.00
Operating Cycle0.000.000.003826.002972.93
Cash Flow Ratios
Operating Cash Flow Per Share-38.73-0.80-2.47-9.17-19.72
Free Cash Flow Per Share-38.73-0.80-2.47-9.17-19.72
Dividend Paid and CapEx Coverage Ratio0.00-290.360.000.000.00
Capital Expenditure Coverage Ratio0.00-290.360.000.000.00
Operating Cash Flow Coverage Ratio0.00-343.15-118.420.00-161.51
Operating Cash Flow to Sales Ratio-58.11-67.81-59.77-61.22-60.54
Free Cash Flow Yield-133.49%-23.89%-105.87%-339.45%-107.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.94-3.56-0.84-0.37-0.72
Price-to-Sales (P/S) Ratio43.53284.7856.4518.0356.38
Price-to-Book (P/B) Ratio0.892.740.270.281.08
Price-to-Free Cash Flow (P/FCF) Ratio-0.75-4.19-0.94-0.29-0.93
Price-to-Operating Cash Flow Ratio-0.75-4.20-0.94-0.29-0.93
Price-to-Earnings Growth (PEG) Ratio0.030.050.010.010.01
Enterprise Value Multiple-0.03-3.090.220.65-0.27
Enterprise Value786.99K122.85M-6.47M-22.31M10.59M
EV to EBITDA-0.03-3.090.220.65-0.27
EV to Sales1.38245.20-15.26-46.7611.37
EV to Free Cash Flow-0.02-3.600.260.76-0.19
EV to Operating Cash Flow-0.02-3.620.260.76-0.19
Tangible Book Value Per Share32.461.228.649.7917.01
Shareholders’ Equity Per Share32.461.228.649.7917.01
Tax and Other Ratios
Effective Tax Rate-0.00-0.000.00-0.00-0.01
Revenue Per Share0.670.010.040.150.33
Net Income Per Share-30.96-0.94-2.77-7.29-25.65
Tax Burden0.991.001.020.681.68
Interest Burden1.001.000.950.991.12
Research & Development to Revenue33.7561.7738.4638.5420.99
SG&A to Revenue19.4426.3331.5434.350.00
Stock-Based Compensation to Revenue4.056.597.799.018.68
Income Quality1.240.850.891.260.77

Currency in USD